IS THERE A RELATIONSHIP BETWEEN SERUM IGF-1 AND THYROID NODULE, THYROID OR OVARIAN VOLUME IN POLYCYSTIC OVARIAN SYNDROME?

Topaloglu O., Evren B., Uzun M., Yologlu S., Guldogan E., Sahin I.

ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.17, sa.1, ss.138-146, 2021 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4183/aeb.2021.138
  • Dergi Adı: ACTA ENDOCRINOLOGICA-BUCHAREST
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
  • Sayfa Sayıları: ss.138-146
  • Anahtar Kelimeler: polycystic ovarian syndrome, IGF 1, thyroid nodule, PCOS, ovarian volume, thyroid volume, GROWTH-FACTOR-I, INSULIN-RESISTANCE, METABOLIC SYNDROME, RISK-FACTOR, PREVALENCE, WOMEN, ASSOCIATION, DISORDERS, PCOS, FEATURES
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Context. Studies investigating the association between serum IGF-1, and thyroid nodule, ovarian or thyroid volume in polycystic ovarian syndrome (PCOS) are limited.